Evidence map›Paper›PMID 31963799›Full record

ArticleMolecules (Basel, Switzerland)2020

Constituents from the Seeds of

Zi-Jian Rong, Gao-Sheng Hu, Shi-Yi Lin, Ting Yan, Na Li, Yue Zhao, Jing-Ming Jia, An-Hua Wang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Nanotechnology-driven nanoemulsion gel for enhanced transdermal delivery ofFrontiers in bioengineering and biotechnology · 2025
    Article
  4. Article
  5. Effects of addingFrontiers in veterinary science · 2023
    Article
  6. Inhibitory effects of aloperine on voltage-gated NaNaunyn-Schmiedeberg's archives of pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zi-Jian RongSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Gao-Sheng HuSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0003-3385-5964
Shi-Yi LinCollege of pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Ting YanSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Na LiSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yue ZhaoSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Jing-Ming JiaSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
An-Hua WangSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.

Funding

National Key R&D Program of China 2017YFC1701200National Natural Science Foundation of China 81374061,81903789
6 · The paper itself

Abstract

Three new isoflavone glucosides, kudonol A-C (

Indexed as

Cell Line, TumorCell ProliferationHumansInhibitory Concentration 50Plant ExtractsProton Magnetic Resonance SpectroscopySeedsSophoraPlant Extractscytotoxicityisoflavone glucosidesS. alopecuroides L.structure elucidation

Identifiers

PMID31963799
PMCPMC7024312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.